- Home
- RCUS vs COMM Comparison
RCUS vs COMM Comparison
Compare RCUS & COMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- COMM
- Stock Information
- Founded
- RCUS 2015
- COMM 1976
- Country
- RCUS United States
- COMM United States
- Employees
- RCUS N/A
- COMM N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- COMM Radio And Television Broadcasting And Communications Equipment
- Sector
- RCUS Health Care
- COMM Technology
- Exchange
- RCUS Nasdaq
- COMM Nasdaq
- Market Cap
- RCUS 1.4B
- COMM 1.1B
- IPO Year
- RCUS 2018
- COMM 2013
- Fundamental
- Price
- RCUS $15.52
- COMM $5.58
- Analyst Decision
- RCUS Buy
- COMM Sell
- Analyst Count
- RCUS 12
- COMM 5
- Target Price
- RCUS $34.50
- COMM $2.50
- AVG Volume (30 Days)
- RCUS 755.7K
- COMM 4.2M
- Earning Date
- RCUS 11-06-2024
- COMM 11-07-2024
- Dividend Yield
- RCUS N/A
- COMM N/A
- EPS Growth
- RCUS N/A
- COMM N/A
- EPS
- RCUS N/A
- COMM N/A
- Revenue
- RCUS $263,000,000.00
- COMM $5,183,800,000.00
- Revenue This Year
- RCUS $127.13
- COMM N/A
- Revenue Next Year
- RCUS N/A
- COMM N/A
- P/E Ratio
- RCUS N/A
- COMM N/A
- Revenue Growth
- RCUS 119.17
- COMM 21.78
- 52 Week Low
- RCUS $13.52
- COMM $0.86
- 52 Week High
- RCUS $20.31
- COMM $7.19
- Technical
- Relative Strength Index (RSI)
- RCUS 44.11
- COMM 52.51
- Support Level
- RCUS $14.78
- COMM $5.24
- Resistance Level
- RCUS $18.07
- COMM $6.90
- Average True Range (ATR)
- RCUS 0.96
- COMM 0.41
- MACD
- RCUS -0.16
- COMM 0.07
- Stochastic Oscillator
- RCUS 22.32
- COMM 39.45
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).